As of Jun 23
| +1.05 / +1.21%|
The 7 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 91.00, with a high estimate of 105.00 and a low estimate of 88.00. The median estimate represents a +4.00% increase from the last price of 87.50.
The current consensus among 7 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.